Get the Stockscreener App
1.3401
4.23%
0.0401
Biofrontera Inc stock is traded at $1.3401, with a volume of 665.58K.
It is up +4.23% in the last 24 hours and up +24.31% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
See More
Previous Close:
$1.30
Open:
$1.36
24h Volume:
665.58K
Relative Volume:
2.00
Market Cap:
$17.28M
Revenue:
$43.20M
Net Income/Loss:
$-11.09M
P/E Ratio:
-1.2086
EPS:
-1.1088
Net Cash Flow:
$-9.32M
1W Performance:
+11.98%
1M Performance:
+24.31%
6M Performance:
+63.25%
1Y Performance:
+45.70%
1-Day Range:
$1.31
$1.3999
1-Week Range:
$1.18
$1.40
52-Week Range:
$0.5547
$1.40
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.35 | 16.64M | 43.20M | -11.09M | -9.32M | -1.1088 |
TAK
Takeda Pharmaceutical Co Adr
|
17.36 | 56.30B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.51 | 42.85B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.59 | 42.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.55 | 30.49B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
507.25 | 21.43B | 3.17B | 1.29B | 1.01B | 27.09 |
Biofrontera Inc Stock (BFRI) Latest News
Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance
Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan
Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review
Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com
BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative
Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times
Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus
Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada
Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore
BFRI Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - The Manila Times
Biofrontera schedules Aug. 13 webcast for business update - Stock Titan
Biofrontera to report Q2 2026 financial results on August 13 with a live webcast. - Pluang
BFRI Q2'26 Earnings: revenue estimate is 9.50M USD - TradingView
Form 4 Biofrontera Inc For: 29 July By Investing.com - Investing.com Canada
Biofrontera Inc. (BFRI) Q1 2026 Earnings: EPS Misses Estimates Sharply Despite Share GainEPS Guidance Update - dars.gov.et
Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRI - TradingView
PTA-Adhoc: Biofrontera AG: Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView
Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView
BFRI|Biofrontera Inc|Price:1.050|Chg%:-0.040 - TradingKey
Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRIW - TradingView
Biofrontera Inc (BFRI) Cash Flow - TradingKey
Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biofrontera Inc (BFRI) Income Statement - TradingKey
Biofrontera Inc (BFRI) Balance Sheet - TradingKey
Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biofrontera Inc (BFRI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biofrontera Inc. Revenue Breakdown – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Holds Steady at $1.09 Amid Low VolatilitySymmetrical Triangle - dars.gov.et
Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin - MSN
Biofrontera Inc. (BFRI) Edges Higher: Support Test and Resistance AheadUpthrust Pattern - dars.gov.et
Biofrontera Inc. Warrants (BFRIW) Holds Steady at $0.03 – Tight Range Signals Stalemate for Penny-Stock WarrantsFear Greed Index - dars.gov.et
Biofrontera Inc. (BFRI) Q1 2026 Earnings: Wider-than-Expected Loss Signals Heavy Investment PhaseMargin Compression Risk - dars.gov.et
Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04Liquidity Sweep - dars.gov.et
Enterprise value to EBIT forward of Biofrontera Inc. – NASDAQ:BFRI - TradingView
BFRI Q1 2026 Earnings: EPS Misses Estimates by a Wide MarginEarnings Surprise Score - dars.gov.et
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):